Status:

UNKNOWN

Metabolomic Analysis of Exhaled Breath Condensate in Asthmatics

Lead Sponsor:

National Taiwan University Hospital

Conditions:

Asthma

Eligibility:

All Genders

20-90 years

Brief Summary

Asthma is a chronic inflammatory airway disease. Significant heterogeneity exists in the clinical manifestations and treatment responses in these patients. Metabolomics is a large-scale approach to mo...

Detailed Description

The aims of this study are: 1. Metabolomic profiling of the exhaled breath condensate (EBC), serum and urine specimens in adult asthmatics; 2. Correlation between metabolomic profiles of these specime...

Eligibility Criteria

Inclusion

  • 20-90 years
  • Diagnosis of asthma based on the GINA guideline

Exclusion

  • Patient with cancer
  • Patient with long-term ventilator use

Key Trial Info

Start Date :

September 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2014

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT01439737

Start Date

September 1 2011

End Date

December 1 2014

Last Update

September 23 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Internal Medicine, National Taiwan University Hospital

Taipei, Taiwan

Metabolomic Analysis of Exhaled Breath Condensate in Asthmatics | DecenTrialz